KLF13 and non-small cell lung carcinoma: In vivo data demonstrated that CAFs‐derived exosomal miR‐3126‐5p facilitated NSCLC progression by targeting KLF13 in both immunodeficient nude mice and immunocompetent C57BL/6N mice.